View frequently asked questions and guidance about the COVID-19 vaccine for Cancer Center patients.
NewsFeb | 2 | 2021
Mass General Cancer Center Joins Leading Cancer Organizations to Warn Cancer Doesn’t Stop for COVID-19 and Neither Should You
Mass General Cancer Center is teaming up with the National Comprehensive Cancer Network® (NCCN®), the American Cancer Society (ACS) and other leading cancer organizations across the country to endorse the resumption of cancer screening and treatment during the ongoing COVID-19 pandemic.
The coalition of 76 organizations has released an open letter reminding the public that cancer still poses a major threat to people’s health, but acting as soon as is safely possible can lead to much better outcomes in the future. The letter examines distressing trends showing a significant drop-off in recommended cancer screening and treatment compared to prior years. This concerning side-effect of the pandemic could lead to a staggering number of preventable cancer deaths over the next ten years and beyond. Oncology experts agree that people should not delay any necessary prevention or care.
Visit NCCN.org/resume-screening to read the entire letter.
Related News and Articles
- Sep | 11 | 2020
Lung screening has the potential to detect lung cancer at earlier stages when it has the best chance of being cured. Learn more in this video from Jo-Anne Shepard, MD, Thoracic Radiologist at the Mass General Cancer Center.
- Sep | 2 | 2020
Pap smears reduce life-threatening cervical cancer by as much as 90%. Learn more in this video from Marcela del Carmen, MD, Gynecologic Oncologist at the Mass General Cancer Center.
- Sep | 4 | 2020
A colonoscopy is the primary and most effective screening technique used to screen patients for colorectal cancer. Learn more in this video from Dr. Ted Hong, GI Radiation Oncologist at the Mass General Cancer Center.
- Sep | 11 | 2020
A mammogram is an X-ray picture of the breast that can find cancer before it can be felt by you or your doctor. Learn more in this video from Dr. Michelle Specht, Breast Surgical Oncologist at the Mass General Cancer Center.